Hep55.1c In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-0123-YF102
Target Cell Organism: Mouse
Target Cell Name: Hep55.1c
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide Hep55.1c-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
Hep55.1c
Target Cell Organism
Mouse
Target Cell Background
The Hep55.1C cell line is derived from carcinogen-induced liver tumors of C57BL/6 mice and utilized in a syngeneic orthotopic murine model of HCC.
Related Diseases
Hepatocellular Carcinoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry